83 related articles for article (PubMed ID: 20551045)
1. Estimating the prevalence of drug injection using a multiplier method based on a register of new HIV diagnoses.
Barrio Anta G; Oliva J; Bravo MJ; De Mateo S; Domingo-Salvany A;
Eur J Public Health; 2011 Oct; 21(5):646-8. PubMed ID: 20551045
[TBL] [Abstract][Full Text] [Related]
2. [The incidence of human immunodeficiency virus type-1 (HIV-1) infection in parenteral drug users].
Aviñó Rico MJ; Hernández Aguado I; Pérez Hoyos S; García de la Hera M; Ruiz I; Bolumar Montrull F
Med Clin (Barc); 1994 Mar; 102(10):369-73. PubMed ID: 8182982
[TBL] [Abstract][Full Text] [Related]
3. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].
de la Fuente L; Bravo MJ; Lew C; Barrio G; Soriano V; Royuela L
Med Clin (Barc); 1999 Nov; 113(17):646-51. PubMed ID: 10618778
[TBL] [Abstract][Full Text] [Related]
4. More free syringes, fewer drug injectors in the case of Spain.
Bravo MJ; Royuela L; Barrio G; de la Fuente L; Suarez M; Teresa Brugal M
Soc Sci Med; 2007 Oct; 65(8):1773-8. PubMed ID: 17658207
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
Spittal PM; Craib KJ; Wood E; Laliberté N; Li K; Tyndall MW; O'Shaughnessy MV; Schechter MT
CMAJ; 2002 Apr; 166(7):894-9. PubMed ID: 11949985
[TBL] [Abstract][Full Text] [Related]
6. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
[TBL] [Abstract][Full Text] [Related]
7. Drug injectors in Glasgow: a community at risk? A report from a multidisciplinary group. The Possilpark Group.
Health Bull (Edinb); 1993 Nov; 51(6):418-29. PubMed ID: 8307755
[TBL] [Abstract][Full Text] [Related]
8. Global HIV cohort studies among injecting drug users and future vaccine trials.
Woratanarat T
J Med Assoc Thai; 2006 Jul; 89(7):1064-79. PubMed ID: 16881444
[TBL] [Abstract][Full Text] [Related]
9. Estimation of injecting drug users in the City of Edinburgh, Scotland, and number infected with human immunodeficiency virus.
Davies AG; Cormack RM; Richardson AM
Int J Epidemiol; 1999 Feb; 28(1):117-21. PubMed ID: 10195675
[TBL] [Abstract][Full Text] [Related]
10. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
11. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
[TBL] [Abstract][Full Text] [Related]
12. Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project.
Des Jarlais DC; Kling R; Hammett TM; Ngu D; Liu W; Chen Y; Binh KT; Friedmann P
AIDS; 2007 Dec; 21 Suppl 8():S109-14. PubMed ID: 18172378
[TBL] [Abstract][Full Text] [Related]
13. Young and recent-onset injecting drug users are at higher risk for HIV.
Fennema JS; Van Ameijden EJ; Van Den Hoek A; Coutinho RA
Addiction; 1997 Nov; 92(11):1457-65. PubMed ID: 9519489
[TBL] [Abstract][Full Text] [Related]
14. An analysis of the effects of HIV infection in a cohort of intravenous drug users.
O'Kelly FD; Bury G
Ir Med J; 1996; 89(3):112-4. PubMed ID: 8707519
[TBL] [Abstract][Full Text] [Related]
15. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
Lima ES; Bastos FI; Telles PR; Friedman SR
Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
[TBL] [Abstract][Full Text] [Related]
16. Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy.
Camoni L; Regine V; Salfa MC; Nicoletti G; Canuzzi P; Magliocchetti N; Rezza G; Suligoi B;
Ann Ist Super Sanita; 2010; 46(1):59-65. PubMed ID: 20348620
[TBL] [Abstract][Full Text] [Related]
17. Estimating the total mortality among problem drug users.
Cruts G; Buster M; Vicente J; Deerenberg I; Van Laar M
Subst Use Misuse; 2008; 43(5):733-47. PubMed ID: 18393087
[TBL] [Abstract][Full Text] [Related]
18. Meth/amphetamine use and associated HIV: Implications for global policy and public health.
Degenhardt L; Mathers B; Guarinieri M; Panda S; Phillips B; Strathdee SA; Tyndall M; Wiessing L; Wodak A; Howard J;
Int J Drug Policy; 2010 Sep; 21(5):347-58. PubMed ID: 20117923
[TBL] [Abstract][Full Text] [Related]
19. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
[TBL] [Abstract][Full Text] [Related]
20. Estimating the number of people at risk for and living with HIV in China in 2005: methods and results.
Lu F; Wang N; Wu Z; Sun X; Rehnstrom J; Poundstone K; Yu W; Pisani E
Sex Transm Infect; 2006 Jun; 82 Suppl 3(Suppl 3):iii87-91. PubMed ID: 16735299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
